Vigorous Anti-Infectious Prophylaxis Reduces Febrile Neutropenia in BR‑Treated Patients With iBC-NHL
Researchers sought to determine whether primary anti-infectious prophylaxis would reduce the incidence of febrile neutropenia and treatment interruptions in older patients with iBC-NHLs.
A higher proportion of patients with pulmonary sarcoidosis were steroid-free after 48 weeks of treatment with efzofitimod vs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results